Below you can find more information about our Management team
Mahesh Narayanan is an entrepreneur in biotechnology with extensive experience in the healthcare and life sciences industry, and a strong focus in business development and business start-up strategies. As President and CEO of PepVax, Inc. and an active member of the Small Business community, he provides business and scientific guidance in the development of cancer therapeutics and immunotherapy. Previously, Mahesh served as a biological research scientist in anti-bacterial and vaccine division at GlaxoSmithKline (GSK). Prior to joining GSK, he consulted through the Penn Biotech Group at Wharton School of Business in healthcare and life science project. Mahesh received his Master’s in Biotechnology from the University of Pennsylvania and his bachelor’s degrees in History and Pre-Medical Sciences from Boston University.
Dr. Anton Dormer is a former associate professor at Washington Adventist University located in Takoma Park, MD. He received a medical doctorate from UTESA and a Master's in Biotechnology and Biomedical Sciences from University of Massachusetts- Boston. Dr. Dormer's research focus is the development of peptide vaccine for the prevention of treatment of makor human pathologies and cancers.
Elton F. Norman graduated, cum laude, from Howard University School of Law in 1994. He served as a member of the Howard Law Review. He earned a BBA in Accounting from Andrews University in 1988. Mr. Norman has extensive experience in financial statements preparation and review and the formation, counseling and governance of business entities. Mr. Norman's work experience includes securities offerings (public and private debt and equity offerings), public company SEC compliance, mergers and acquisitions, venture capital financing, for-profit and non-profit corporate formations and corporate counseling. Mr. Norman also has significant experience working with small and start-up businesses. Mr. Norman worked for approximately ten (10) years as a corporate/securities attorney for major law firms before founding The Norman Law Firm PLLC, where he is currently the managing member.
Dr. Daniel Achinko is a research scientist at the University of Yaounde I (UYI), Cameroon. He received his doctorate in Bioinformatics with a focus on co-parasitic infections, and a Master's in Molecular Parasitology with a focus on genotyping the Plasmodium strains of Malaria. He is curently a member of the East African Bioinformatics Group and the International Society of Computational Biology